A clinical trial of MK-1568 in participants with prostate cancer (MK-1568-001)
Sponsor: Merck Sharp & Dohme LLC
Phase: 1
Disease: Prostate cancer
EU trial number: 2026-526983-19-00
Population: Adult male patients with prostate cancer participating in MK-1568-001; available CTIS data does not specify disease stage, previous treatments, biomarker eligibility or dosing.
Register Investigator Interest
Interested in offering this trial to suitable patients?